DU PONT E I DE NEMOURS & CO INC -- SUVA MP39 (R401A) -- 6830-00D006819
=====================  Product Identification  =====================

Product ID:SUVA MP39 (R401A)
MSDS Date:10/05/1996
FSC:6830
NIIN:00D006819
=== Responsible Party ===
Company Name:DU PONT E I DE NEMOURS & CO INC
Address:1007 MARKET STREET
Box:1635
City:WILMINGTON
State:DE
ZIP:19898
Country:US
Info Phone Num:800-441-7515/MSDS 302-992-3511
Emergency Phone Num:800-441-3637/800-424-9300(CHEMTREC)
Preparer's Name:DUPONT CHEMICALS
CAGE:18873
=== Contractor Identification ===
Company Name:DU PONT FLUOROPRODUCTS
Address:1007 MARKET STREET
Box:City:WILMINGTON
State:DE
ZIP:19898
Country:US
Phone:1-800-441-7515
CAGE:2S827
Company Name:E.I. DUPONT DE NEMOURS & CO
Address:1007 MARKET STREET
Box:City:WILMINGTON
State:DE
ZIP:19898
Country:US
Phone:800-441-7515;800-441-9442
CAGE:18873

=============  Composition/Information on Ingredients  =============

Ingred Name:CHLORODIFLUOROMETHANE (SARA 313) (CERCLA)
CAS:75-45-6
RTECS #:PA6390000
Fraction by Wt: 53%
Other REC Limits:NONE RECOMMENDED
OSHA PEL:1000 PPM
ACGIH TLV:1000 PPM; 9596
Ozone Depleting Chemical:2

Ingred Name:1,1DIFLUOROETHANE
CAS:75-37-6
RTECS #:KI1410000
Fraction by Wt: 13%
Other REC Limits:NONE RECOMMENDED

Ingred Name:2-CHLORO-1,1,1,2-TETRAFLUOROETHANE (SARA 313)
CAS:2837-89-0
Fraction by Wt: 34%
Other REC Limits:NONE RECOMMENDED

=====================  Hazards Identification  =====================

LD50 LC50 Mixture:AEL DUPONT: 1000 PPM 8 & 12 HR TWA
Routes of Entry: Inhalation:YES  Skin:YES  Ingestion:NO
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:INHALATION OF HIGH CONCENTRATIONS OF
    VAPOR IS HARMFUL & MAY CAUSE HEART IRREGULARITIES, UNCONSCIOUSNESS,
    OR DEATH. INTENTIONAL MISUES OR DELIBERATE INHALATION MAY CAUSE
    DEATH WITHOUT WARNING. VAPOR RE DUCES OXYGEN AVAILABLE FOR
    BREATHING AND IS HEAVIER THAN AIR. LIQUID CONTACT CAN CAUSE
    FROSTBITE.
Explanation of Carcinogenicity:NO INGREDIENT OF A CONCENTRATION OF 0.1%
    OR GREATER IS LISTED AS A CARCINOGEN OR SUSPECTED CARCINOGEN.
Effects of Overexposure:SKIN CONTACT MAY CAUSE FROSTBITE FROM EXPOSURE
    TO THE LIQUID. INHALATION MAY INCLUDE NONSPECIFIC DISCOMFORT, SUCH
    AS NAUSEA, HEADACHE, OR WEAKNESS OR TEMPORARY NERVOUS SYSTEM
    DEPRESSION WITH ANESTHETI C EFFECTS SUCH AS DIZZINESS, HEADACHE,
    CONFUSION, INCOORDINATION AND LOSS OF CONSCIOUSNESS.
Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MANUFACTURER.

=======================  First Aid Measures  =======================

First Aid:INHALATION: REMOVE TO FRESH AIR. KEEP PERSON CALM, IF NOT
    BREATHING, GIVE ARTIFICIAL RESPIRATION. IF BREATHING IS DIFFICULT,
    GIVE OXYGEN. SKIN: FLUSH W/WATER TREAT FOR FROSTBITE IF NECESSARY
    BY GENTLY  WARMING AFFECTED AREA. EYES: FLUSH W/PLENTY OF WATER FOR
    15 MINUTES. OBTAIN MEDICAL ATTENTION IN ALL CASES.

=====================  Fire Fighting Measures  =====================

Flash Point Method:TOC
Flash Point:WILL NOT BURN
Autoignition Temp:Autoignition Temp Text:681C
Lower Limits:NONE
Upper Limits:NONE
Extinguishing Media:USE MEDIA APPROPRIATE FOR SURROUNDING MATERIAL.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND
    FULL FIRE FIGHTER'S PROTECTIVE GEAR. USE WATER TO COOL FIRE EXPOSED
    CONTAINERS.
Unusual Fire/Explosion Hazard:CYLINDERS MAY RUPTURE UNDER FIRE
    CONDITIONS. DECOMPOSITION MAY OCCUR.

==================  Accidental Release Measures  ==================

Spill Release Procedures:VENTILATE AREA, ESPECIALLY LOW/ENCLOSED PLACES
    WHERE HEAVY VAPORS MIGHT COLLECT. REMOVE OPEN FLAMES. USE SELF-
    CONTAINED BREATHING APPARATUS IF LARGE SPILL OR LEAK OCCURS.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

======================	Handling and Storage  ======================

Handling and Storage Precautions:STORE IN A CLEAN, DRY PLACE. DO NOT
    HEAT ABOVE 52C (126F).
Other Precautions:AVOID BREATHING VAPORS OR MIST. AVOID CONTACT WITH
    EYES OR SKIN. USE WITH SUFFCIENT VENTILATION TO KEEP EMPLOYEE
    EXPOSURE BELOW THE RECOMMENDED LIMIT.

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:UNDER NORMAL MANUFACTURUNG CONDITIONS, NO
    RESPIRATORY PROTECTION IS REQUIRED WHEN USING THIS PRODUCT.
    SELF-CONTAINED BREATHING APPARATUS IS REQUIRED IF LARGE RELEASE
    OCCURS.
Ventilation:LOCAL EXHAUST IF LARGE AMOUNTS ARE RELEASED. MECHANICAL
    VENTILATION SHOULD BE USEDD IN LOW/ENCLOSED PLACES.
Protective Gloves:LINED BUTYL GLOVES.
Eye Protection:CHEMICAL SPLASH GOGGLES.
Other Protective Equipment:NONE SPECIFIED BY MANUFACTURER.
Work Hygienic Practices:WASH CONTAMINATED CLOTHING BEFORE REUSE.
Supplemental Safety and Health
NOTE TO PHYSICIAN: BECAUSE OF POSSIBLE DISTURBANCES OF CARDIAC RHYTHM,
    CATECHOLAMINE DRUGS, SUCH AS EPINEPHRINE, SHOULD ONLY BE USED WITH
    SPECIAL CAUTION.

==================  Physical/Chemical Properties  ==================

HCC:G3
Boiling Pt:B.P. Text:-27F,-33C
Vapor Pres:5798
Vapor Density:3.3
Evaporation Rate & Reference:>1 (CCL4=1.0)
Solubility in Water:NEGLIGIBLE, 0.1%
Appearance and Odor:CLEAR, COLORLESS LIQUIFIED GAS, ETHER (SLIGHT)
    ODOR.
Percent Volatiles by Volume:100

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
INCOMPATIBLE W/ALKALI OR ALKALINE EARTH METALS- POWEDERED AL, ZN, BE,
    ETC.
Stability Condition to Avoid:AVOID OPEN FLAMES AND HIGH TEMPERATURES.
Hazardous Decomposition Products:HYDROCHLORIC AND HYDROFLUORIC ACIDS &
    POSSIBLE CARBONYL HALIDES.
Conditions to Avoid Polymerization:POLYMERIZATION WILL NOT OCCUR.

====================  Disposal Considerations  ====================

Waste Disposal Methods:COMPLY WITH FEDERAL, STATE & LOCAL REGULATIONS
    FOR REPORTING RELEASES.

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.